Lifetech KONAR MFO Post-Market Clinical Follow-Up Study

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 4, 2019

Primary Completion Date

March 30, 2022

Study Completion Date

June 30, 2023

Conditions

Ventricular Septal Defect

Interventions

DEVICE

KONAR-MF™ VSD Occluder

All patients will be implanted with a KONAR-MF™ VSD Occluder in accordance with the instructions for use (IFU).

Trial Locations (4)

101 - Deutsches Herzzentrum der Charité/ German Heart Institute Berlin, Berlin

IRCCS Policlinico San Donato, Milan

103 - Herz- und Diabeteszentrum NRW / Heart and Diabetes Center NRW, Bad Oeynhausen

102 - Deutsches Herzzentrum München/ German Heartcenter Munich, Munich

All Listed Sponsors

lead

Lifetech Scientific (Shenzhen) Co., Ltd.

INDUSTRY

NCT04417712 - Lifetech KONAR MFO Post-Market Clinical Follow-Up Study | Biotech Hunter | Biotech Hunter